+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

UPM-Kymmene Corp (UPM) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 61 Pages
  • July 2026
  • GlobalData
  • UPM
  • ID: 1314960
UPM-Kymmene Corp (UPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

UPM-Kymmene Corp (UPM) is a biomaterial company that provides renewable alternatives to fossil-based materials. The company engages in the production of pulp, graphic and specialty papers, self-adhesive labels, wood-based renewable diesel, electricity, plywood, and timber products. UPM's brands include WISA plywood and UPM Biofuels. Its products serve a diverse range of industries, including packaging, labeling, automotive, construction, and publishing. UPM's customer base includes publishers, cataloguers, retailers, printers, and merchants, with applications spanning from tissue and hygiene to automotive and transport. The company operates a comprehensive distribution network with factories and terminals worldwide. The company has operations across the Americas, Asia, Europe, Oceania, and Africa. UPM is headquartered in Helsinki, Finland.

UPM-Kymmene Corp Key Recent Developments

  • Jun 15, 2026: UPM Adhesive Materials Highlights Climate Progress and Value Chain Collaboration in 2025 Climate Review
  • Jun 11, 2026: UPM Communication Papers Climate Report Shows Major Progress Toward 2030 Target
  • Jun 03, 2026: Changes in UPM's Executive Team: Joonas Rauramo Appointed Head of UPM Energy
  • May 13, 2026: UPM-Kymmene Oyj Acquires Ray Technology Intellectual Property From Avantium

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Orion Corp - Key Facts
  • Orion Corp - Key Employees
  • Orion Corp - Key Employee Biographies
  • Orion Corp - Major Products and Services
  • Orion Corp - History
  • Orion Corp - Company Statement
  • Orion Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Orion Corp - Business Description
  • Product Category: Animal Health
  • Overview
  • Performance
  • Product Category: Branded Products
  • Overview
  • Performance
  • Product Category: Fermion and Contract Manufacturing
  • Overview
  • Performance
  • Product Category: Generics and Consumer Health
  • Overview
  • Performance
  • Product Category: Innovative Medicines
  • Overview
  • Performance
  • Geographical Segment: Finland
  • Performance
  • Geographical Segment: North America
  • Performance
  • Geographical Segment: Other Europe
  • Performance
  • Geographical Segment: Rest of the World
  • Performance
  • Geographical Segment: Scandinavia
  • Performance
  • R&D Overview
  • Orion Corp - Corporate Strategy
  • Orion Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Orion Corp - Strengths
  • Orion Corp - Weaknesses
  • Orion Corp - Opportunities
  • Orion Corp - Threats
  • Orion Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Orion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Orion Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 12, 2026: Orion Animal Health Receives US FDA Approval for Tessie (tasipimidine) for Noise Aversion and Separation Anxiety in Dogs
  • May 12, 2026: Orion Animal Health Receives FDA Approval for Tessie Product (Tazepidone Oral Solution)
  • May 04, 2026: Orion Corporation Managers’ Transactions - Minna Maasilta
  • Apr 23, 2026: Orion Group Interim Report January-March 2026
  • Apr 09, 2026: Orion’s Production Processes in Turku to Become Carbon-Free With New Steam Plant
  • Apr 07, 2026: The Many Paths a Pharmacy Degree Can Open in the Pharmaceutical Industry
  • Apr 01, 2026: Orion Group Executive Team Change: Berkeley Vincent Appointed Executive Vice President, Innovative Medicines
  • Mar 18, 2026: Peace through well-being: Orion and CMI - Martti Ahtisaari Peace Foundation announce partnership
  • Mar 10, 2026: Orion Corporation Managers’ Transactions - Mikko Kemppainen
  • Feb 27, 2026: Orion Group's Financial Statements for 2025 and Remuneration Report Published
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Orion Corp, Key Facts
  • Orion Corp, Key Employees
  • Orion Corp, Key Employee Biographies
  • Orion Corp, Major Products and Services
  • Orion Corp, History
  • Orion Corp, Subsidiaries
  • Orion Corp, Key Competitors
  • Orion Corp, Ratios based on current share price
  • Orion Corp, Annual Ratios
  • Orion Corp, Interim Ratios
  • Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Orion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Orion Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Orion Corp, Performance Chart (2021 - 2025)
  • Orion Corp, Ratio Charts
  • Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Orion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026